These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 2614728)
1. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas. Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728 [TBL] [Abstract][Full Text] [Related]
2. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. Scarpignato C; Varga G; Dobronyi I; Papp M Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo. Niederau M; Niederau C; Strohmeyer G; Grendell JH Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767 [TBL] [Abstract][Full Text] [Related]
4. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas. Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223 [TBL] [Abstract][Full Text] [Related]
5. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Schmidt WE; Choudhury AR; Siegel EG; Löser C; Conlon JM; Fölsch UR; Creutzfeldt W Regul Pept; 1989 Jan; 24(1):67-79. PubMed ID: 2544930 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide. Varga G; Papp M; Scarpignato C Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419 [TBL] [Abstract][Full Text] [Related]
7. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog. Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149 [TBL] [Abstract][Full Text] [Related]
8. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog. de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545 [TBL] [Abstract][Full Text] [Related]
9. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas. Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365 [TBL] [Abstract][Full Text] [Related]
10. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Digestion; 1989; 42(2):61-9. PubMed ID: 2475379 [TBL] [Abstract][Full Text] [Related]
11. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat. Varga G; Kisfalvi K; D'Amato M; Scarpignato C J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804 [TBL] [Abstract][Full Text] [Related]
12. Antagonism of receptors for bombesin, gastrin and cholecystokinin in pancreatic secretion and growth. Konturek SJ; Dembinski A; Warzecha Z; Jaworek J; Konturek PK; Cai RZ; Schally AV Digestion; 1991; 48(2):89-97. PubMed ID: 1714408 [TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini]. Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035 [TBL] [Abstract][Full Text] [Related]
15. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
17. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists. Varga G; Scarpignato C Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627 [TBL] [Abstract][Full Text] [Related]
18. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade. Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465 [TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs. Thor P; Laskiewicz J; Konturek P; Konturek SJ Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646 [TBL] [Abstract][Full Text] [Related]
20. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]